Breaking NewsElixinol Global's £20m Swoop For Leading German CBD Firm

Elixinol Global’s £20m Swoop For Leading German CBD Firm

-

GERMAN CBD firm CannaCare Health makers of the popular brand CANOBO has been snapped up by Australian company Elixinol Global for a potential €24m. 

Established in 2018 CANOBO has a presence in 4,500 German ‘High Street’ outlets, and an extensive range of more than 20 products consisting of CBD oils, sprays and skincare lines.

CannaCare’s revenues totalled €2.6m in 2020, and in tandem with Elixinol’s UK operations the aim is to create a pan-European business of scale, says Elixinol Global CEO Oliver Horn. 

He added: “We are incredibly excited about this transformational opportunity, which leapfrogs Elixinol closer to its vision of becoming a profitable, global, hemp-derived consumer goods wellness business.”

Hamburg-based CannaCare has secured a presence for CANOBO in 2,200 Rossmann stores – Germany’s leading drugstore chain and is active in the TV advertising space.

As part of the transaction Frank Otto of CannaCare will be appointed to the Elixinol Board as a Non-Executive Director.

Elixinol Global is listed on the Australian Securities Exchange. Full details of the nature of the transaction can be found here.



Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Thought Leaders Acquisition Of mellow Set To Accelerate Growth Across UK, Europe, And Asia Footprint

THE CBD world is set with a massive shake-up this week as Thought Leaders, the US cannabis & CBD investment company,...

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council have been identified following a special general meeting attended by...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science, Dr Anne Katrin Schlag, heads up the newly formed Cannabis...

European Cannabis Market Leader Bloomwell Group Secures $10m Investment

The Bloomwell Group has successfully closed a seed funding round of over $10 million dollars—the highest publicly known seed investment...

German Hemp Farm Numbers Up 900% In Seven Years – As industry Calls For Post-Election Reform

THE number of German farms growing industrial hemp has hit 863 – the highest figure since the federal republic...

US Company Set To Launch UK Medical Cannabis Study In Partnership With Manchester University

A GROUND-BREAKING human pilot study centred on the University of Manchester could provide answers to using cannabis as a...

Must read

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science,...

You might also likeRELATED
Recommended to you